Literature DB >> 10835447

Ischemic heart disease in black South African stroke patients.

J Joubert1, C A McLean, C M Reid, D Davel, W Pilloy, R Delport, L Steyn, A R Walker.   

Abstract

BACKGROUND AND
PURPOSE: Stroke patients in western countries frequently have coronary artery disease (CAD). In black Africans, CAD has been reported as being rare in both stroke patients and the general population. In this study, an attempt has been made to determine the prevalence of CAD in a black South African stroke population.
METHODS: The prevalence of CAD was determined by indicators identified through a series of 5 observational studies in black patients diagnosed with stroke. CAD indicators included (1) bedside diagnosis in 741 patients; (2) resting ECG in 555 consecutively admitted patients; (3) a combination of clinical examination, cardiac ultrasound, radionuclide scintigraphy, and multigated blood pool studies in 102 consecutively admitted patients; (4) thallium scintigraphy in 60 patients; and (5) necropsy in 23 patients.
RESULTS: On bedside questioning, only 0.7% complained of previous angina. There was no history given of myocardial infarction (MI), but documentation of this was found in the clinical notes of 0.7% of the patients. In the resting ECG study, evidence of myocardial ischemia was present in 14.6% and MI in 2.1%. In the combined study, cardiac ischemia was documented on ECG in 12.7% of patients and evidence of previous MI in 5.8%. Cardiac scintigraphic studies revealed changes of myocardial ischemia in 31.7% and MI in 13.3% of the 60 patients studied. Four (17.4%) of 23 patients in the necropsy study had histological evidence of previous MI, and 50% of all patients had evidence of >50% atherosclerotic stenosis in 1, 2, or 3 coronary arteries.
CONCLUSIONS: The prevalence of CAD in black African stroke patients is significantly higher than has been documented in the general nonstroke black population as well as in stroke patients. Black stroke patients may have a risk for CAD similar to that of their white counterparts.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10835447     DOI: 10.1161/01.str.31.6.1294

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  7 in total

1.  The waist circumference of risk in black South african men is lower than in men of European ancestry.

Authors:  W John Kalk; Barry I Joffe; Anne E Sumner
Journal:  Metab Syndr Relat Disord       Date:  2011-08-29       Impact factor: 1.894

2.  The pattern and prognostic features of QT intervals and dispersion in patients with acute ischemic stroke.

Authors:  Oluranti B Familoni; Olatunde Odusan; S Abayomi Ogun
Journal:  J Natl Med Assoc       Date:  2006-11       Impact factor: 1.798

Review 3.  National prevalence of coronary heart disease and stroke in South Africa from 1990-2017: a systematic review and meta-analysis.

Authors:  Nada Abdelatif; Nasheeta Peer; Samuel O Manda
Journal:  Cardiovasc J Afr       Date:  2021-03-26       Impact factor: 1.167

4.  Prevalence and determinants of electrocardiographic abnormalities in sub-Saharan African individuals with type 2 diabetes.

Authors:  A Dzudie; S-P N Choukem; A K Adam; A P Kengne; P Gouking; M Dehayem; F Kamdem; M S Doualla; H A Joko; M E Lobe; Y M Mbouende; H Luma; J C Mbanya; S Kingue
Journal:  Cardiovasc J Afr       Date:  2012-09-19       Impact factor: 1.167

Review 5.  Acute myocardial infarction in sub-Saharan Africa: the need for data.

Authors:  Julian T Hertz; Joseph M Reardon; Clarissa G Rodrigues; Luciano de Andrade; Alexander T Limkakeng; Gerald S Bloomfield; Catherine A Lynch
Journal:  PLoS One       Date:  2014-05-09       Impact factor: 3.240

Review 6.  Epidemiology of ischaemic heart disease in sub-Saharan Africa.

Authors:  Churchill Lukwiya Onen
Journal:  Cardiovasc J Afr       Date:  2013-03       Impact factor: 1.167

7.  Clinical risk predictors associated with cardiac mortality following vascular surgery in South African patients.

Authors:  B M Biccard; R Bandu
Journal:  Cardiovasc J Afr       Date:  2007 Jul-Aug       Impact factor: 1.167

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.